In a preclinical mouse study, selective deletion of HIF-1α in T cells led to increased tumor growth and decreased T cell tumor infiltration, survival, and effector function, measured by production of TNFα and IFNγ (116). The gene discussed is IFNG; the disease is neoplasm.